318010 — Pharmsville Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro CapContrarian

Annual income statement for Pharmsville Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	29,952	39,409	39,028	26,113	21,395
Cost of Revenue
Gross Profit	22,290	27,448	25,782	15,843	13,162
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Total Operating Expenses	22,845	35,102	32,868	22,050	19,762
Operating Profit	7,107	4,306	6,159	4,063	1,633
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	9,207	3,442	6,164	5,192	3,966
Provision for Income Taxes
Net Income After Taxes	7,236	2,870	4,996	4,064	3,307
Minority Interest
Net Income Before Extraordinary Items
Net Income	7,256	2,891	5,000	4,063	3,310
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	7,256	2,891	5,000	4,063	3,310
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,093	370	637	514	426
Dividends per Share